Next Generation in Protein Characterization
RedShiftBio’s AQS3pro Wins a ‘The Analytical Scientist Innovation Award’ (TASIA) 2018
TASIA showcases the technologies driving the advancement of measurement science.
The Next Generation in Protein Characterization
The AQS3pro launches a new era in IR spectroscopy and protein characterization, bringing repeatable, high sensitivity, automated measurements to every stage of the biopharmaceutical pipeline. Powered by Microfluidic Modulation Spectroscopy (MMS), the AQS3pro measures the secondary structure of proteins over nearly four decades of concentration, from 0.1 mg/ml to over 200 mg/ml. Driven by the industry-leading AQS3delta Analytical Software package, it streamlines and simplifies 5 key measurements:
Aggregation | Quantitation | Stability | Structure | Similarity
See change in your protein, in your workflow, and in your efficiency.
Biotherapeutics and Vaccines Development
Gordon Research Conference, Jan 6-11, 2019, Galveston, TX
Peptalk 2019, Jan 14-18, 2019, San Diego, CA
WCBP, Jan 29 - 31, 2019, Washington, DC
RedShift™, RedShiftBio™, See Change™, and AQS3™ are trademarks of RedShift BioAnalytics, Inc.